Julia Edwards

Julia Edwards is Senior Vice President of Global Regulatory Affairs - CMC and Devices at Eli Lilly and Company, where she leads regulatory strategy across biologics, synthetic molecules, cell and gene therapies, combination products, and diagnostics. With nearly 22 years of global regulatory expertise, she has guided regulatory pathways from early development through lifecycle management across diverse international markets. Prior to joining Lilly, Julia spent more than a decade at Genentech, most recently as Senior Vice President and Global Head of Pharma Technical Regulatory, leading a global organization spanning nine countries. Her experience includes leadership roles at Genentech, Allergan, and Biogen, driving regulatory strategy for some of the industry's most innovative therapeutic portfolios. Julia is committed to advancing regulatory science through collaboration with health authorities worldwide. She has served as President and Vice President of the Board of Directors for CASSS, a not-for-profit professional scientific society comprising over 7,000 industry, academic, and regulatory professionals globally, where she helped shape industry dialogue and foster partnerships to advance biopharmaceutical science. Julia holds an MBA from The Wharton School and a BS in Chemical Engineering from UC Berkeley. Her approach centers on harmonizing scientific innovation with regulatory excellence to accelerate patient access to life-changing therapies.